Your browser doesn't support javascript.
loading
Development and implementation of guidelines for the management of depression: a systematic review.
Lee, Yena; Brietzke, Elisa; Cao, Bing; Chen, Yan; Linnaranta, Outi; Mansur, Rodrigo B; Cortes, Paulina; Kösters, Markus; Majeed, Amna; Tamura, Jocelyn K; Lui, Leanna M W; Vinberg, Maj; Keinänen, Jaakko; Kisely, Steve; Naveed, Sadiq; Barbui, Corrado; Parker, Gary; Owolabi, Mayowa; Nishi, Daisuke; Lee, JungGoo; Srisurapanont, Manit; Gill, Hartej; Guo, Lan; Balanzá-Martínez, Vicent; Partonen, Timo; Nolen, Willem A; Lee, Jae-Hon; Kim, Ji Hwan; Chavannes, Niels H; Ewais, Tatjana; Atienza-Carbonell, Beatriz; Silven, Anna V; Yasuma, Naonori; Gil, Artyom; Novikov, Andrey; Lacey, Cameron; Versluis, Anke; von Malortie, Sofia; Chan, Lai Fong; Waqas, Ahmed; Purgato, Marianna; Aardoom, Jiska Joëlle; Ly-Uson, Josefina T; Sim, Kang; Tuineag, Maria; van der Kleij, Rianne M J J; van Luenen, Sanne; Suttajit, Sirijit; Hajek, Tomas; Lee, Yu Wei.
Afiliación
  • Lee Y; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Brietzke E; Department of Psychiatry, Queen's University School of Medicine, Kingston, Canada.
  • Cao B; School of Psychology and Key Laboratory of Cognition and Personality, Southwest University, Chongqing, China.
  • Chen Y; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Linnaranta O; Bipolar Disorders Clinic, Douglas Mental Health University Institute, Montréal, Canada.
  • Mansur RB; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Cortes P; Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile.
  • Kösters M; Department of Psychiatry II, Ulm University, Ulm, Germany.
  • Majeed A; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Tamura JK; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Lui LMW; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Vinberg M; Psychiatric Research Unit, Psychiatric Centre North Zealand, Hilleroed, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Keinänen J; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
  • Kisely S; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
  • Naveed S; Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas, USA.
  • Barbui C; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Biomedicine and Movement Sciences, Verona, Italy.
  • Parker G; Global Alliance for Chronic Diseases, Wellcome Trust, London, England.
  • Owolabi M; Center for Genomics and Precision Medicine, University of Ibadan, Ibadan, Nigeria.
  • Nishi D; Department of Mental Health, The University of Tokyo, Tokyo, Japan.
  • Lee J; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea.
  • Srisurapanont M; Department of Psychiatry, Chiang Mai University, Chiang Mai, Thailand.
  • Gill H; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Guo L; School of Public Health, Sun Yat-sen University, Guangdong, China.
  • Balanzá-Martínez V; Teaching Unit of Psychiatry and Psychological Medicine, University of Valencia, Valencia, CIBERSAM, Spain.
  • Partonen T; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
  • Nolen WA; Department of Psychiatry, University of Groningen, Groningen, Netherlands.
  • Lee JH; Department of Psychiatry, Gyeongsang National University Hospital, Jinju, Republic of Korea.
  • Kim JH; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea.
  • Chavannes NH; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
  • Ewais T; School of Clinical Medicine, The University of Queensland, Brisbane, Australia.
  • Atienza-Carbonell B; Medical School, University of Valencia, Valencia, Spain.
  • Silven AV; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
  • Yasuma N; Department of Mental Health, The University of Tokyo, Tokyo, Japan.
  • Gil A; WHO European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programme, Moscow, Russian Federation.
  • Novikov A; Psychiatric and Neurological Hospital, Surgut, Russian Federation.
  • Lacey C; Maori Indigenous Health Institute, University of Otago, Christchurch, New Zealand.
  • Versluis A; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
  • von Malortie S; The National Board of Health and Welfare, Stockholm, Sweden.
  • Chan LF; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Waqas A; Department of Psychiatry, Queen's University School of Medicine, Kingston, Canada.
  • Purgato M; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Aardoom JJ; School of Psychology and Key Laboratory of Cognition and Personality, Southwest University, Chongqing, China.
  • Ly-Uson JT; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Biomedicine and Movement Sciences, Verona, Italy.
  • Sim K; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
  • Tuineag M; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • van der Kleij RMJJ; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • van Luenen S; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Suttajit S; Bipolar Disorders Clinic, Douglas Mental Health University Institute, Montréal, Canada.
  • Hajek T; Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst St 9MP-325, Toronto, Ontario, Canada.
  • Lee YW; Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana, Chile.
Bull World Health Organ ; 98(10): 683-697H, 2020 Oct 01.
Article en En | MEDLINE | ID: mdl-33177758
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Depresión / Trastorno Depresivo Mayor Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: Bull World Health Organ Año: 2020 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Depresión / Trastorno Depresivo Mayor Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: Bull World Health Organ Año: 2020 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza